Peter Steven St's Net Worth

$6.89 Million

Estimate Recalculated Nov 8, 2024 04:38PM EST

Who is Peter Steven St?

Peter Steven St has an estimated net worth of $6.89 Million. This is based on reported shares across multiple companies, which include Omrix Biopharmaceuticals, Inc., PEPLIN INC, Radius Health, Inc., Verastem, Inc., HEALTHCARE ACQUISITION CORP, Pacira Pharmaceuticals, Inc., ARATANA THERAPEUTICS, INC., HELICOS BIOSCIENCES CORP, and MEMORY PHARMACEUTICALS CORP.

SEC CIK

Peter Steven St's CIK is 0001352447

Past Insider Trading and Trends

2016 was Peter Steven St's most active year for acquiring shares with 9 total transactions. Peter Steven St's most active month to acquire stocks was the month of December. 2016 was Peter Steven St's most active year for disposing of shares, totalling 11 transactions. Peter Steven St's most active month to dispose stocks was the month of August. 2014 saw Peter Steven St paying a total of $150,000.00 for 510,207 shares, this is the most they've acquired in one year. In 2015 Peter Steven St cashed out on 100,000 shares for a total of $1,889,055.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PEPLIN INC No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.42M
—
—
0
Nov 11
Form 4
+0.07%
2.25K
$8.11
$18,233.80
3.42M
Feb 11 - Feb 12
Form 4
+0.03%
1K
$8.00
$7,992.00
3.42M
Feb 9
Form 4
+0.08%
2.65K
$7.80
$20,654.40
3.42M
Feb 5
Form 4
+0.23%
7.71K
$8.04
$61,948.00
3.41M
Jan 23 - Jan 27
Form 4
+0.10%
3.52K
$8.07
$28,369.80
3.41M
Jan 21 - Jan 22
Form 4
+0.29%
9.88K
$8.14
$80,402.20
3.4M
Jan 15 - Jan 20
Form 4
+0.20%
6.91K
$7.03
$48,584.33
3.39M
Jan 13
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

MEMORY PHARMACEUTICALS CORP No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-14.14M
$0.61
-$8,624,785.73
0
Jan 1
Form 4
—
0
—
—
14.24M
Feb 28
Form 4
—
0
—
—
14.24M
Jun 30
Form 4
-0.19%
-27.60K
$2.10
-$57,960.00
14.14M
Sep 14
Form 4
-0.51%
-72.18K
$2.13
-$153,731.06
14.17M
Sep 12 - Sep 13
Form 4
+25.00%
2.85M
$1.33
$3,787,512.82
14.24M
Feb 12
Form 4
+25.51%
2.32M
$1.11
$2,569,817.61
11.39M
Dec 18
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Verastem, Inc. (VSTM) Snapshot price: $2.44

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+105.17%
2.03M
$10.00
$1,000,000.00
3.97M
Feb 1
Form 3
—
0
—
—
0
No matching records found

MPM ACQUISITION CORP No price found

President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 14
Form 4
—
0
—
—
0
Nov 18
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Omrix Biopharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+100.00%
2K
—
—
4K
Sep 4
Form 4
—
0
$20.88
-$47,355.00
2K
Aug 13
Form 4
∞
2K
—
—
2K
May 31
Form 4
—
0
—
—
0
Jun 27
Form 3
—
0
—
—
0
No matching records found